Insulin therapy in Type 2 Diabetes patients

Insulin therapy in Type 2 Diabetes patients

F.Hadaegh MD

Associate professor of internal medicine and endocrinology

Prevention of Metabolic Disorders Research Center

Research Institute for Endocrine Sciences

More than 1% of the Iranian urban population older than 20 years develops Type 2 diabetes each year.
If we extrapolate the standardized annual rate of the incident diabetes to the current urban population of IRAN older than 20 years, it is estimated that each year more than 310, 000 individuals develop Type 2 diabetes.
This alarming rate confirms previous estimates that the Middle East region will have the highest increase in number of diabetes cases in the following 20 years
According to the National Health Interview Survey, 28% of patients with type 2 diabetes are using insulin, alone (16%) or combined with oral antidiabetic drugs(12%) .
Even with the basal-bolus regimen (best regimen ?) the proportion of patients with a HbA_1c goal of <7% was ONLY 63.5%???

“duration of disease, unsuccessful titration of insulin dose, and fear of hypoglycemia”